Even though the FDA has approved some drugstores to custom made-combine versions of semaglutide, there have already been studies citing adverse outcomes from these. Novo Nordisk and Eli Lilly have also documented impurities during the compounded medicines.to cut back the risk of important cardiovascular situations like heart attack, stroke, or deat